Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
M&A / Property

Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH

OGI · Price

Executive Summary

  • ISS recommends shareholders vote FOR the transaction to acquire Sanity Group GmbH, citing strong strategic rationale, credible valuation, and positive market reaction.
  • The acquisition involves an upfront consideration of €113.4 million (€80 M cash + €33.4 M Organigram shares) at a 71.4% premium, plus up‑to €113.8 million earn‑out tied to post‑closing performance.
  • Board and independent directors unanimously support the deal; related matters (director elections, auditor appointment, equity incentive plan re‑approval) will also be voted on at the March 30, 2026 meeting.

Key Details

  • ISS Recommendation (dated Mar 14, 2026): Vote FOR the Transaction Resolution. Highlights include:
  • Compelling strategic rationale – scale, geographic diversification, stronger balance sheet, enhanced cash flow.
  • Strong institutional confidence – connected private placement by BAT at a meaningful premium.
  • Credible valuation – fairness opinion from BMO Nesbitt Burns confirming financial fairness.
  • Positive market reaction – OGI shares outperformed TSX indices after announcement.
  • Transaction Terms:
  • Sanity shareholders receive cash and Organigram shares valued at C$3.00 per share (≈71.4% premium to pre‑announcement price).
  • Total upfront consideration: €113.4 million (€80 M cash + €33.4 M Organigram shares).
  • Contingent earn‑out: up to €113.8 million, based on Sanity’s financial performance in the 12 months post‑closing.
  • Board Position: Unanimous recommendation (interested directors abstained) to vote FOR; board consulted advisors and obtained fairness opinion from BMO Nesbitt Burns.
  • Shareholder Meeting Details:
  • Date & Time: Monday, March 30, 2026 at 10:00 a.m. Toronto time, 333 Bay Street, Suite 3400, Toronto.
  • Audio‑only conference available for non‑attendees (no voting). Dial‑in numbers and registration URL provided.
  • Additional Matters on the Meeting Agenda:
  • Election of ten director nominees.
  • Appointment of PricewaterhouseCoopers LLP as auditor.
  • Re‑approval of all unallocated awards under the Omnibus Equity Incentive Plan.
  • Voting Deadline: 10:00 a.m. Toronto time, Thursday, March 26, 2026.

Notable Quotes

  • “The strategic rationale for the deal makes sense and the combined company should be able to harness benefits from increased scale, diversification, improved market presence, a stronger balance sheet, and cash flow generation.” – ISS report excerpt.

Prepared based on the press release dated March 23, 2026.

Read the original news release →

More from ORGANIGRAM GLOBAL INC.